.png)
Leadership appointment demonstrating Zigzag’s commitment to the expansion of its global quality services.
Cambridge, April 4, 2024 – Zigzag Associates Ltd, a leading provider of sponsor research and development quality and compliance consulting services, is thrilled to announce the appointment of Marieke Kirkman as the company's Chief Commercial Officer (CCO).
In her new role as Chief Commercial Officer, Kirkman will be responsible for leading the company's commercial strategy, expanding its market presence, and driving revenue growth. She will work closely with the executive team to identify new business opportunities, enhance client relationships, and further strengthen Zigzag’s position as the trusted partner in research quality and compliance consulting.
"I am thrilled to appoint Marieke to our executive team," said Julie Beal, CEO. "Her extensive experience and proven leadership skills will be instrumental in driving our growth trajectory. With Marieke onboard, we are confident in our ability to continue delivering exceptional value to our clients and achieving our strategic quality objectives."
Kirkman expressed her excitement about her appointment stating, "I am honored to grow with Zigzag at such an exciting time. Our commitment to growth and providing best in class quality will be a game changer in ensuring our clients see a lasting, streamlined impact on their quality programs. I look forward to leveraging my quality and compliance experience to contribute to the company's success and further strengthen its position as a leader in the pharmaceutical service provider industry."
About Zigzag Associates:
Zigzag is a United Kingdom headquartered consulting firm, with global office locations, specializing in pharmaceutical research quality and compliance. With a team of experienced professionals and deep industry expertise, we provide comprehensive consulting services to pharmaceutical companies, helping them navigate regulatory requirements, optimize quality systems, and ensure compliance throughout the drug development process.
For more information, please contact us here: https://www.zigzagassociates.com/contact-us